Europe Healthcare Cold Chain Logistics Market Share, Revenue, Trends, Growth Drivers, CAGR Status, Challenges and Future Investment Strategies Till 2033

Share

Europe Healthcare Cold Chain Logistics Market Share, Revenue, Trends, Growth Drivers, CAGR Status, Challenges and Future Investment Strategies Till 2033: SPER Market Research



 Published: Mar-2024
 Author: SPER Analyst


Europe Healthcare Cold Chain Logistics Market is projected to be worth USD 23.98 billion by 2033 and is anticipated to surge at a CAGR of 9.98%. 

Cold chain logistics in healthcare refers to the careful movement and storage of biologics, medications, and other temperature-sensitive goods in a regulated environment along the whole supply chain. From the manufacturing process to the end-user, who may be a patient or a healthcare practitioner, this procedure guarantees that these items retain their safety and efficacy. The infrastructure of the cold chain logistics consists of refrigerated trucks, warehouses, and packaging solutions with temperature-monitoring devices installed to maintain the necessary temperature range, which is typically 2°C to 8°C for many pharmaceuticals and even ultra-low temperatures for some biologics and vaccines.

Europe Healthcare Cold Chain Logistics Market Driving Factors and Challenges

Drivers: It is anticipated that OTC pharmaceutical use will increase significantly. During the pandemic, consumers in Europe have shown a discernible increase in health awareness. Self-care has the ability to address these issues by empowering individuals and creating more convenient access to healthcare services. These factors have contributed to the expansion of cold chain logistics in European healthcare. The need for over-the-counter (OTC) medications and self-care products has increased as a result of people becoming more proactive about managing their health. As a result, the growth of e-commerce platforms has made OTC medication consumption in Europe more accessible to consumers. The simplicity of purchasing healthcare products via electronic channels is the reason for the expansion of this market. 

Challenges: One of the main challenges facing the European healthcare cold chain logistics market is the complexity of storing and shipping pharmaceuticals, biologics, and medical devices at temperature-sensitive levels. The efficacy and security of medical products must be ensured at every point in the supply chain, from manufacturing to delivery and distribution, by maintaining strict temperature control. Temperature changes that happen during storage or transportation of these products could harm them, reduce their efficacy, or even have unfavorable consequences on patients.


Impact of COVID-19 on Europe Healthcare Cold Chain Logistics Market
The COVID-19 pandemic has had a major impact on the Europe Healthcare Cold Chain Logistics Market, posing both opportunities and challenges. Because vaccines and other vital medical supplies must be distributed quickly, cold chain logistics services are in high demand. Ensuring the safe and efficient carriage of temperature-sensitive COVID-19 vaccines, such as those that require ultra-low temperatures, like Pfizer-BioNTech's mRNA vaccine, presented unprecedented challenges to the healthcare cold chain.

Europe Healthcare Cold Chain Logistics Market Key Players:
The market study provides market data by competitive landscape, revenue analysis, market segments and detailed analysis of key market players are; Alloga, Biocair, Carrier Transicold, Cavalier Logistics, DB Schenker, DHL, Envirotainer, Kuehne + Nagel, Marken Ltd, Primafrio, and other.


Europe Healthcare Cold Chain Logistics Market Segmentation:

By Product: Based on the Product, Europe Healthcare Cold Chain Logistics Market is segmented as; Biopharmaceuticals, Vaccines, Clinical Trial Materials.

By Services: Based on the Services, Europe Healthcare Cold Chain Logistics Market is segmented as; Transportation, Storage, Packaging and Labelling, Others.

By End User: Based on the End User, Europe Healthcare Cold Chain Logistics Market is segmented as; Hospitals, Clinics and Pharmaceuticals, Biopharmaceutical, Biotechnology.

By Region: This research also includes data for Germany, France, Italy, Spain, UK, Rest of Europe.

This study also encompasses various drivers and restraining factors of this market for the forecast period. Various growth opportunities are also discussed in the report.

Join Our SPER Panel

Our Global Clients

Our data-driven insights have influenced the strategy of 200+ reputed companies across the globe.
SPER-Astellas Pharma
SPER-Citi Bank
SPER-Microsoft
SPER-EY
SPER-McKinsey
SPER-Bain
SPER-Max-Healthcare
SPER-DHL
SPER-SIEMENS
SPER-IQVIA
SPER-Pfizer
SPER-LOREAL
SPER-Kankar IMRB
SPER-ITA
SPER-PWC
SPER-Sanofi
SPER-p&g
SPER-Johnson & Johnson
SPER-IPSOS
SPER-Heineken

SPER

Market Research

We are the leading, full-service global market research and consulting company.

Certificates
iso-1 iso-1 iso-1 ESOMAR
Secure Payments
SPER Payment Options
Contact HR

 [email protected]

 +91-742-898-5650